In eukaryotes, gene expression is controlled by a relatively small number of regulators. Post-translational modifications dramatically increase the functional possibilities of those regulators. Modification of many transcription factors and cofactors by SUMO (small ubiquitin-related modifier) correlates, in most cases, with inhibition of transcription. Recent studies suggest a model whereby SUMO conjugation to transcription factors promotes the recruitment of co-repressors through direct protein-protein interaction with the SUMO protein. HDACs (histone deacetylases) are important, but not exclusive, effectors of SUMO-mediated repression. Sp3 (specificity protein 3), a zinc-finger DNA-binding domain transcription factor, has the ability to both activate and repress transcription in a context-dependent manner. SUMOylation regulates the dual nature of Sp3 function. Current data suggest that Sp3 represses transcription in a SUMO-dependent manner but independent of HDACs. Recent studies to identify additional co-repressors associated with SUMO and further investigate regulated activity of Sp3 are providing a deeper understanding of SUMO-dependent mechanisms of transcriptional regulation.
The dual function of Sp3
Sp3 belongs to the Sp (specificity protein) family of transcription factors and, as a member of this group of regulators, controls expression of genes implicated in different processes including cell-cycle-regulated, hormone-induced and housekeeping genes. Sp3, Sp1 and Sp4 share a highly conserved zinc-finger DNA-binding domain, allowing them to interact with the same GC/GT motifs within promoters ( Figure 1 ) [1] . In addition to the DNA-binding domain, Sp3 has other functional domains similar to Sp1 [2] [3] [4] [5] including two glutaminerich transactivation domains, each of which can stimulate transcription when tethered to DNA through a DNAbinding domain, and serine/threonine-rich subregions located next to the glutamine-rich region, which are believed to be involved in regulation via post-translational modification [6, 7] . The functional complexity of Sp3 may be increased by the presence of at least two internal translation initiation sites within the Sp3 mRNA, which give rise, in addition to a fulllength protein, to two shorter Sp3 isoforms [8] . As a member of a web of structurally related transcription factors working through the same DNA recognition motif, the effect of Sp3 on genes is likely to be intimately associated with the activity of other Sp factors. Early studies of Sp3 −/− mice revealed some redundant functions with other Sp family members, but these studies also revealed specific non-redundant functions of Sp3 in the differentiation of several cell types [9] .
At the time it was first characterized, a major distinct feature of Sp3 compared with other members of the Sp family was its ability to both activate and repress transcription, either by competition with Sp1 or by actively repressing [10, 11] . In order to explain the dual transcriptional effect of Sp3 at a molecular level, attention was mostly focused on a single lysine residue within the inhibitory domain located between the second transactivation domain and the first zinc-finger domain. Mutation of this lysine residue turns Sp3 from either a weak activator or repressor into a strong activator [12] . Studies by our laboratory and others [13, 14] demonstrated that this lysine residue was the target for conjugation of the SUMO (small ubiquitin-related modifier) post-translational modifier. This lysine residue, within a consensus IKEE motif, is the main, if not the only, SUMO target residue of Sp3 in vivo. The role of SUMO in the Sp3 transcriptional function was further demonstrated in co-transfection assays with the SUMO-specific protease SuPr1. SuPr1 expression greatly stimulated the activity of wild-type Sp3, but not a nonSUMOylatable lysine-to-arginine mutant. These results suggested that SUMOylation of Sp3 is one of the main regulatory events controlling the activity of this transcription factor and potentially the molecular switch that determines whether Sp3 functions as an activator or a repressor ( Figure 2 ) [13] .
SUMO provides a platform for protein-protein interactions
The SUMO protein is a post-translational modifier with structural similarities to ubiquitin but different functional roles. To date, and with few exceptions, SUMOylation of transcription factors and cofactors correlates with loss of activation or enhancement of the repressory activity of those transcription factors. In some cases, increased stability by competition with the ubiquitin pathway [15] and regulation of binding to promoter DNA [16] have been described as mechanisms associated with the SUMO modification of some transcription factors. The most frequent mechanism linked to the regulation of transcription factors by SUMO conjugation, however, seems to be repression of transcription mediated by non-covalent interaction with co-repressory activities [17] [18] [19] . Consistent with this protein-protein interaction model (Figure 2) , fusion of SUMO protein in tandem with the SUMOylation defective mutant of Sp3 was enough to repress transcriptional activation by Sp3, indicating that neither the specific SUMO acceptor lysine residue nor the relative position of SUMO are important for the repressive effect on Sp3 [13] . Furthermore, fusion of either SUMO-1 or SUMO-2 to the GAL4 DNA-binding domain is sufficient to repress transcription, suggesting that SUMO has an intrinsic repression function [13, 20] .
The model that SUMO promotes non-covalent interactions with co-repressor activities implies the existence of a SUMO-interacting motif in those effectors. Several groups have proposed as potential SIMs (SUMO interaction motifs) similar short stretches of hydrophobic residues (isoleucine, valine and leucine), flanked either C-or N-terminally by acidic residues [21] [22] [23] . This motif interacts non-covalently with specific residues within the SUMO surface. Extensive mutational analysis of SUMO-2 identified basic residues important for its intrinsic repressor function [24] . Mutation of these basic residues on the SUMO surface of the previously described GAL4-SUMO-Sp3KR fusion proteins, promoted de-repression of its activity [25] , further supporting the role of SUMO as a platform for the recruitment of co-repressor activities to Sp3.
SUMO promotes association with diverse co-repressors
Loss of histone acetylation at the promoter region generally correlates with gene repression. Recent investigations have identified HDAC activity as a mediator of the SUMOdependent effect on several transcription factors. HDAC activity seems to mediate the SUMO repressor function for the transcription factor Elk-1 [ETS (E twenty-six)-like kinase 1] [20] . Yang et al. [20] have shown that HDAC2 interacts with Elk-1 in a SUMO-dependent manner, correlating with an increased association of HDAC2 and decreased levels of histone acetylation at an Elk-1-regulated promoter. Similarly, SUMOylation of MafG [26] and the NuRD (nucleosome remodelling and deacetylase) complex subunit p66α [27] correlate with recruitment of HDAC activity and increased transcriptional repression.
Even though HDACs seem to have an important role in the repressor function of SUMO, they are not likely to be the only effectors of SUMO-dependent activity. Using an affinity chromatography approach, we identified the histone H3K9 methyltransferase SETDB1 [SET (suppressor of variegation/enhancer of zeste/trithorax) domain bifurcated 1] and the lysine-specific demethylase LSD1 as proteins noncovalently associated with SUMO-2 [25] , suggesting that regulation of histone methylation may also contribute to SUMO-dependent regulation of gene expression. The transcriptional repression mechanism of MBD1 (methylCpG-binding domain protein 1) is HDAC-independent and is mediated by the recruitment of SETDB1 and its cofactor MCAF1 (MBD1-containing chromatin-associated factor 1) [28] [29] [30] . Uchimura et al. [31] have shown that SUMOylation of MBD1 by SUMO-2/3 or SUMO-1 facilitates the interaction with MCAF1 both in vitro and in vivo. Further immunolocalization studies suggested a link between SUMOylation of MBD1 and MBD1-dependent heterochromatin formation. In apparent contradiction, a second study by Lyst et al. [32] reported that conjugation of SUMO-1 to MBD1 antagonized its interaction with SETDB1 and further repression of the p53BP2 promoter. Clearly, a deeper investigation of the role of SUMO in the MBD1-SETDB1-MCAF system is called for, but the authors raise the interesting possibility of an opposing effect of SUMO-1 compared with SUMO-2/3 conjugation to MBD1 that could perhaps explain this apparent contradictory set of data. Further mapping of the SUMObinding domains in these chromatin regulators will also be important, as competing interactions of SUMO-MCAF and SETDB1 could also contribute to context-dependent effects.
In addition to the association with methyltransferase activity, SUMO may also regulate histone methylation status through association with the demethylase LSD1. Non-covalent association of LSD1 with SUMO-2 was demonstrated by affinity purification of GST (glutathione Stransferase)-SUMO-2-associated proteins from a cell extract [25] . Consistent with the recruitment of LSD1 by SUMO-2, chromatin immunoprecipitation assays demonstrated a dramatic reduction of H3K4 dimethylation levels of a GAL4-TK promoter vector by a GAL4-SUMO-2 fusion protein.
Taken together, these studies suggest that SUMO may regulate chromatin structure and gene expression through association with diverse histone-modifying enzymes.
Sp3 may repress transcription through HDAC-dependent and -independent mechanisms
SUMOylation regulates the repression function of Sp3 through a still unknown mechanism. Consistent with the role of histone deacetylation in SUMO-dependent repression, HDACs have been suggested to play a major role in the transcriptional repression of Sp3. HDAC2 interacts with Sp3 [33, 34] , probably within the context of the mSin3A HDAC complex [35] [36] [37] . Although HDACs seem to play an important role in the repressor activity of Sp3, as does SUMO, data provided by Spengler et al. [38] suggest that the SUMO-dependent repressor activity of the small Sp3 isoforms is HDAC-independent. Treatment with the HDAC inhibitor TSA (trichostatin A) was reported to similarly increase the activity of both wild-type Sp3 M1 isoform and the SUMOylation-defective mutant, suggesting a SUMOindependent function of HDACs in the Sp3 activity. We have obtained similar results using a full-length GAL4-Sp3 fusion protein (A. Valin and G. Gill, unpublished work), suggesting the presence of HDAC-dependent and -independent repressor mechanisms for Sp3. Current studies to identify SUMO-dependent co-repressors of Sp3 will provide new insights into the diverse mechanisms by which SUMO regulates gene expression.
Challenges ahead
Post-translational modification by SUMO contributes to the complex activities of the dual-function transcription factor Sp3. Interestingly, the highly related transcription factor Sp1 has recently been added to the growing list of transcription factors and cofactors modified by SUMO [39] . Thus SUMO may regulate context-dependent activities of both Sp1 and Sp3, and the molecular basis for functional specificity between these related transcription factors remains an open question. SUMO is proposed to regulate transcription in large part by promoting interactions with co-repressors. Recent studies suggest that multiple histone-modifying activities including deacetylases, methyltransferases and demethylases are among the many transcriptional regulators that interact non-covalently with SUMO and this list of SUMO-associated transcription factors is likely to grow. The number and diversity of SUMO-interacting proteins, together with possible functional differences among the SUMO paralogues, suggest a highly complex and versatile role for SUMO in regulation of chromatin structure and gene expression. Identification of the co-repressors that contribute to SUMO-dependent regulation of Sp3-dependent transcription is expected to provide further insights into how the functional complexity that the SUMO system can provide contributes to the complex, context-dependent, activities of the dual-function transcription factor Sp3.
